Energy-rich therapy for chronic fatigue syndrome

The study included 84 children aged 12—16 years with chronic fatigue syndrome in the presence of mitral valve prolapse (MVP), who were treated with L-carnitine (Elcar 30%) and Coenzyme Q10 (Kudevita). L-carnitine is involved in metabolic processes as a carrier of long-chain fatty acids from the cyto...

Full description

Bibliographic Details
Main Authors: M. T. Baedilova, S. E. Lebed'kova, O. Yu. Trusova, V. V. Sumenko, T. N. Ignatova
Format: Article
Language:Russian
Published: Ltd. “The National Academy of Pediatric Science and Innovation” 2016-03-01
Series:Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:
Online Access:https://www.ped-perinatology.ru/jour/article/view/103